Clinical Trial Update: S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib [Phase 2]

View source ↗

Summary

Phase 2 trial of pemetrexed disodium with or without crizotinib in stage IV non-small cell lung cancer progressed after crizotinib; study terminated with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Crizotinib (crizotinib)
• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Adenocarcinoma of the Lung, Large Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2019-05-01